P E Thorpe

2.3k total citations
50 papers, 1.9k citations indexed

About

P E Thorpe is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, P E Thorpe has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 21 papers in Molecular Biology and 20 papers in Biotechnology. Recurrent topics in P E Thorpe's work include Toxin Mechanisms and Immunotoxins (31 papers), Transgenic Plants and Applications (20 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). P E Thorpe is often cited by papers focused on Toxin Mechanisms and Immunotoxins (31 papers), Transgenic Plants and Applications (20 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). P E Thorpe collaborates with scholars based in United Kingdom, United States and Germany. P E Thorpe's co-authors include Francis Burrows, Rolf A. Brekken, A.J. Cumber, D C Blakey, W. C. J. Ross, Brian M. J. Foxwell, P.P. Knowles, A N Brown, G Watson and J.A. Forrester and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

P E Thorpe

48 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P E Thorpe United Kingdom 27 951 904 672 466 304 50 1.9k
M J Glennie United Kingdom 17 764 0.8× 857 0.9× 160 0.2× 867 1.9× 578 1.9× 25 2.2k
John W. Marks United States 27 389 0.4× 1.3k 1.5× 178 0.3× 264 0.6× 388 1.3× 58 2.4k
Peisheng Hu United States 29 986 1.0× 722 0.8× 132 0.2× 697 1.5× 812 2.7× 62 2.0k
H. Durbin United Kingdom 20 492 0.5× 940 1.0× 101 0.2× 1.0k 2.2× 645 2.1× 27 2.3k
Shengle Zhang United States 24 821 0.9× 1.5k 1.6× 117 0.2× 612 1.3× 596 2.0× 65 2.4k
Isolda Casanova Spain 27 418 0.4× 1.0k 1.1× 175 0.3× 199 0.4× 709 2.3× 67 1.9k
Luis E. Fernández Cuba 31 1.3k 1.4× 1.1k 1.3× 132 0.2× 577 1.2× 544 1.8× 70 2.2k
Isaiah J. Fidler United States 16 296 0.3× 816 0.9× 269 0.4× 131 0.3× 750 2.5× 20 1.7k
Wolfgang Kemmner Germany 24 714 0.8× 1.7k 1.9× 129 0.2× 192 0.4× 624 2.1× 63 2.5k
Aïcha Demidem France 21 333 0.4× 544 0.6× 74 0.1× 273 0.6× 250 0.8× 50 1.5k

Countries citing papers authored by P E Thorpe

Since Specialization
Citations

This map shows the geographic impact of P E Thorpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P E Thorpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P E Thorpe more than expected).

Fields of papers citing papers by P E Thorpe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P E Thorpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P E Thorpe. The network helps show where P E Thorpe may publish in the future.

Co-authorship network of co-authors of P E Thorpe

This figure shows the co-authorship network connecting the top 25 collaborators of P E Thorpe. A scholar is included among the top collaborators of P E Thorpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P E Thorpe. P E Thorpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Phil, P E Thorpe, Juliet Goldbart, et al.. (2025). Academic progress in learners with profound intellectual disabilities: analysis of a Routes for Learning dataset. European Journal of Special Needs Education. 41(2). 333–350.
2.
Chen, Ning, Chang‐Yong Kim, Jian Wang, et al.. (2010). Investigations of mechanical vibrations for beamlines at the Canadian Light Source. Journal of Synchrotron Radiation. 18(2). 109–116. 9 indexed citations
3.
Jennewein, M., Α. Hermanne, Ralph P. Mason, P E Thorpe, & Frank Rösch. (2006). A new method for the labelling of proteins with radioactive arsenic isotopes. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 569(2). 512–517. 26 indexed citations
4.
Tsyganov, E., J. A. Anderson, Gary Arbique, et al.. (2006). UTSW Small Animal Positron Emission Imager. IEEE Transactions on Nuclear Science. 53(5). 2591–2600. 5 indexed citations
5.
Jennewein, M., S.M. Qaim, Α. Hermanne, et al.. (2005). A new method for radiochemical separation of arsenic from irradiated germanium oxide. Applied Radiation and Isotopes. 63(3). 343–351. 44 indexed citations
6.
Pickering, W., et al.. (2004). Characterization of the cell‐surface procoagulant activity of T‐lymphoblastoid cell lines. Journal of Thrombosis and Haemostasis. 2(3). 459–467. 16 indexed citations
7.
Thorpe, P E & Sophia Ran. (2002). Mapping zip codes in human vasculature. The Pharmacogenomics Journal. 2(4). 205–206. 7 indexed citations
8.
Brekken, Rolf A. & P E Thorpe. (2001). VEGF–VEGF receptor complexes as markers of tumor vascular endothelium. Journal of Controlled Release. 74(1-3). 173–181. 39 indexed citations
9.
Thorpe, P E. (1997). Targeting of tumor vasculature. 153–154. 2 indexed citations
10.
Winkler, U., Claudia Gottstein, Gisela Schön, et al.. (1994). Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins. Blood. 83(2). 466–475. 32 indexed citations
11.
Thorpe, P E, Sílvia Passos Andrade, Nancy Press, et al.. (1993). Heparin-steroid conjugates: new angiogenesis inhibitors with antitumor activity in mice.. PubMed. 53(13). 3000–7. 45 indexed citations
12.
Engert, Andreas, Claudia Gottstein, U. Winkler, et al.. (1992). [New perspectives in oncology: is selective destruction of tumor cells with immunotoxins in Hodgkin's disease an additional therapeutic alternative?].. PubMed. 87(10). 503–9. 1 indexed citations
13.
Blakey, D C & P E Thorpe. (1988). Treatment of Malignant Disease and Rheumatoid Arthritis Using Ricin A-chain Immunotoxins. Scandinavian Journal of Rheumatology. 17(sup76). 279–287. 2 indexed citations
14.
Stirpe, Fiorenzo, et al.. (1988). Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin. British Journal of Cancer. 58(5). 558–561. 14 indexed citations
15.
Glennie, Martin J., H M McBride, Fiorenzo Stirpe, et al.. (1987). Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin.. The Journal of Experimental Medicine. 166(1). 43–62. 37 indexed citations
16.
Thorpe, P E. (1985). Intra-articular triamcinolone acetonide and methylprednisolone acetate in arthritis. Current Therapeutic Research. 38(3). 513–518. 10 indexed citations
17.
Thorpe, P E, et al.. (1984). An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A. Blood. 63(5). 1178–1185. 47 indexed citations
18.
Thorpe, P E, Simone Detre, Donald W. Mason, A.J. Cumber, & W. C. J. Ross. (1983). Monoclonal Antibody Therapy: “Model” Experiments with Toxin-Conjugated Antibodies in Mice and Rats. Hämatologie und Bluttransfusion. 28. 107–111. 4 indexed citations
19.
Mason, Donald W., P E Thorpe, & W. C. J. Ross. (1982). Elimination of leukaemic cells from rodent bone marrow in vitro with antibody-ricin conjugates: Implications for autologous marrow transplantation in man. 1(3). 389–415. 7 indexed citations
20.
Thorpe, P E, et al.. (1957). CALIBRATION OF THE MERCURY VAPOUR DETECTOR TYPE "B". OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 19(9). 1833–1843.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026